AI assistant
Sending…
Roivant Sciences Ltd. — Director's Dealing 2020
Feb 28, 2020
30587_dirs_2020-02-27_2fac2d29-05c1-4200-93bb-e99df7316057.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Axovant Gene Therapies Ltd. (AXGT)
CIK: 0001636050
Period of Report: 2020-02-24
Reporting Person: Roivant Sciences Ltd. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-24 | Common Shares, par value $0.00001 per share | P | 5333333 | $3.75 | Acquired | 18577380 | Direct |
More from Roivant Sciences Ltd.
Registration Form
2026
May 20
Annual Report
2026
May 20
Regulatory Filings
2026
May 20
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 18